Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CME GROUP INC.CME · Entity 2909 | Director | April 24, 2025 | April 28, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CME GROUP INC.
Report date April 24, 2025 · Filed April 28, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Class ASEC Table I · non-derivative | Direct | 36,651.15 |
Ending reported balance
After 2025-04-25 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2025-04-24 · Sale · Disposed 1,000 · Balance 39,651.15 Row 2 · 2025-04-24 · Sale · Disposed 1,000 · Balance 38,651.15 F1: On April 24, 2025, Mr. Gerdes sold an aggregate of 1,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $265.00 to $265.17. The Company maintains a record of the transaction and copies will be provided upon request. Row 3 · 2025-04-25 · Sale · Disposed 2,000 · Balance 36,651.15 F2: On April 25, 2025, Mr. Gerdes sold an aggregate of 2,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $266.01 to $266.34. The Company maintains a record of the transaction and copies will be provided upon request. |
Filing footnotes · ownership attribution and instrument terms
F1: On April 24, 2025, Mr. Gerdes sold an aggregate of 1,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $265.00 to $265.17. The Company maintains a record of the transaction and copies will be provided upon request.
F2: On April 25, 2025, Mr. Gerdes sold an aggregate of 2,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $266.01 to $266.34. The Company maintains a record of the transaction and copies will be provided upon request.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 25, 2025 Filed Apr 28, 2025 12:02 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 2,000 | $266.12 | $532,238.80 |
DisclosureSEC source: 0001156375-25-000100 · wk-form4_1745856163.xml · nonDerivative · entry 3 GERDES LARRY G · CIK 0000925105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,651.15 F2 · price: On April 25, 2025, Mr. Gerdes sold an aggregate of 2,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $266.01 to $266.34. The Company maintains a record of the transaction and copies will be provided upon request. Read SEC document |
| April 24, 2025 Filed Apr 28, 2025 12:02 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 1,000 | $265.10 | $265,102.60 |
DisclosureSEC source: 0001156375-25-000100 · wk-form4_1745856163.xml · nonDerivative · entry 2 GERDES LARRY G · CIK 0000925105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,651.15 F1 · price: On April 24, 2025, Mr. Gerdes sold an aggregate of 1,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $265.00 to $265.17. The Company maintains a record of the transaction and copies will be provided upon request. Read SEC document |
| April 24, 2025 Filed Apr 28, 2025 12:02 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 1,000 | $263.10 | $263,100.00 |
DisclosureSEC source: 0001156375-25-000100 · wk-form4_1745856163.xml · nonDerivative · entry 1 GERDES LARRY G · CIK 0000925105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,651.15 Read SEC document |
| June 25, 2024 Filed Jun 26, 2024 20:46 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 1,237 | $194.10 | $240,101.70 |
DisclosureSEC source: 0001156375-24-000123 · wk-form4_1719449182.xml · nonDerivative · entry 1 GERDES LARRY G · CIK 0000925105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,651.15 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 12:17 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 1,342 | $178.89 | $240,070.38 |
DisclosureSEC source: 0001156375-23-000104 · wf-form4_168796902440130.xml · nonDerivative · entry 1 GERDES LARRY G · CIK 0000925105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,414.15 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 27, 2022 Filed Jun 29, 2022 10:31 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 1,146 | $209.44 | $240,018.24 |
DisclosureSEC source: 0001156375-22-000195 · wf-form4_165651307750266.xml · nonDerivative · entry 1 GERDES LARRY G · CIK 0000925105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,072.15 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 15:21 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 75 | $221.79 | $16,634.25 |
DisclosureSEC source: 0001156375-22-000026 · wf-form4_164322844771796.xml · nonDerivative · entry 1 GERDES LARRY G · CIK 0000925105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,926.15 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2021 Filed Jun 29, 2021 21:25 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 917 | $218.12 | $200,016.04 |
DisclosureSEC source: 0001156375-21-000086 · edgardoc.xml · nonDerivative · entry 1 GERDES LARRY G · CIK 0000925105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,851.15 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 18:11 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 1,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000057 · edgardoc.xml · nonDerivative · entry 1 GERDES LARRY G · CIK 0000925105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,934.15 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2019 Filed Jun 27, 2019 15:29 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 1,009 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-19-000063 · edgardoc.xml · nonDerivative · entry 1 GERDES LARRY G · CIK 0000925105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,748.15 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| September 25, 2018 Filed Sep 27, 2018 17:09 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 173 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-18-000109 · edgardoc.xml · nonDerivative · entry 1 GERDES LARRY G · CIK 0000925105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,739.15 F1 · shares: Incremental grant made pursuant to the CME Group Director Stock Plan, as amended and restated, as a result of an increase to Board compensation. Read SEC document |
| June 25, 2018 Filed Jun 27, 2018 13:40 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 961 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-18-000063 · edgardoc.xml · nonDerivative · entry 1 GERDES LARRY G · CIK 0000925105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,566.15 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 18:00 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 1,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000069 · edgardoc.xml · nonDerivative · entry 1 GERDES LARRY G · CIK 0000925105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,605.15 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.